Founded in 2014 by entrepreneurs and scientists, Orig3n is leading a transformation in the understanding and treatment of rare, genetically inherited diseases.
Our science is based on Nobel Prize-winning regenerative medicine technology, and our approach will replace the trial-and-error guesswork of diagnosing and treating disease.
We've established the world's largest uniformly consented cell repository to better understand the cellular and molecular foundations of disease. The cells are ever-renewing and give rise to a living database of humanity we call LifeCapsule. This biorepository is used to create LifeSystems cellular models available to help researchers accelerate the development of safer and more effective drugs.
Visit Orig3n.com for more information.